JP2002531573A5 - - Google Patents

Download PDF

Info

Publication number
JP2002531573A5
JP2002531573A5 JP2000586741A JP2000586741A JP2002531573A5 JP 2002531573 A5 JP2002531573 A5 JP 2002531573A5 JP 2000586741 A JP2000586741 A JP 2000586741A JP 2000586741 A JP2000586741 A JP 2000586741A JP 2002531573 A5 JP2002531573 A5 JP 2002531573A5
Authority
JP
Japan
Prior art keywords
group
alkyl
nucleoside derivative
groups
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000586741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002531573A (ja
JP4879398B2 (ja
Filing date
Publication date
Priority claimed from DE19855963A external-priority patent/DE19855963A1/de
Application filed filed Critical
Publication of JP2002531573A publication Critical patent/JP2002531573A/ja
Publication of JP2002531573A5 publication Critical patent/JP2002531573A5/ja
Application granted granted Critical
Publication of JP4879398B2 publication Critical patent/JP4879398B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000586741A 1998-12-04 1999-12-03 グリセリルヌクレオチド、それらの製造法および使用 Expired - Fee Related JP4879398B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19855963.1 1998-12-04
DE19855963A DE19855963A1 (de) 1998-12-04 1998-12-04 Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
PCT/EP1999/009461 WO2000034298A1 (de) 1998-12-04 1999-12-03 Glycerylnucleotide, verfahren zu ihrer herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
JP2002531573A JP2002531573A (ja) 2002-09-24
JP2002531573A5 true JP2002531573A5 (https=) 2010-09-24
JP4879398B2 JP4879398B2 (ja) 2012-02-22

Family

ID=7889957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000586741A Expired - Fee Related JP4879398B2 (ja) 1998-12-04 1999-12-03 グリセリルヌクレオチド、それらの製造法および使用

Country Status (10)

Country Link
US (1) US6787525B1 (https=)
EP (1) EP1135401B1 (https=)
JP (1) JP4879398B2 (https=)
AT (1) ATE243220T1 (https=)
AU (1) AU1558800A (https=)
CA (1) CA2352229C (https=)
DE (2) DE19855963A1 (https=)
DK (1) DK1135401T3 (https=)
ES (1) ES2201805T3 (https=)
WO (1) WO2000034298A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10228059B4 (de) * 2002-06-19 2005-12-29 Eberhard-Karls-Universität Tübingen Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten
US7593913B2 (en) * 2006-01-11 2009-09-22 Siemens Medical Solutions Usa, Inc. Systems and method for integrative medical decision support
EP2619215B1 (en) 2010-09-22 2018-09-05 Alios Biopharma, Inc. Azido nucleosides and nucleotide analogs
SG10201913554YA (en) 2011-12-22 2020-03-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
MX2014014323A (es) 2012-05-25 2015-02-12 Janssen R & D Ireland Nucleosidos de espirooxetano de uracilo.
BR112015014457A2 (pt) 2012-12-21 2017-11-21 Alios Biopharma Inc composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c
WO2015054465A1 (en) 2013-10-11 2015-04-16 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03236396A (ja) * 1990-02-10 1991-10-22 Tosoh Corp 修飾オリゴデオキシヌクレオチド及びそれを含むdna
JPH0421694A (ja) * 1990-05-16 1992-01-24 Asahi Chem Ind Co Ltd 新規なヌクレオシド―リン脂質複合体
WO1991019726A1 (en) * 1990-06-15 1991-12-26 Wake Forest University Ether lipid-nucleoside covalent conjugates
CA2129986C (en) 1992-02-13 2003-12-09 Albert Reto Schwendener Amphiphile nucleosidphosphatanaloga
DE4418690A1 (de) * 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
JP4259611B2 (ja) * 1994-08-29 2009-04-30 ウェイク フォレスト ユニバーシティ ウィルス感染を治療するための脂質アナログ
WO1998028978A1 (en) * 1996-05-08 1998-07-09 Weider Nutrition Group, Inc. Structured glycerols and structured phosphatides
US6686462B2 (en) * 1997-02-28 2004-02-03 The Regents Of The University Of California Antiviral compounds and methods of administration

Similar Documents

Publication Publication Date Title
JP2002531573A5 (https=)
JP2009513753A5 (https=)
JPH10265454A5 (https=)
JP2005538057A5 (https=)
JP2005507443A5 (https=)
JP2004501940A5 (https=)
KR840007596A (ko) 유기인 유도체의염의 제조방법
JP2001055446A5 (https=)
JP2004051995A5 (https=)
JP2006527285A5 (https=)
JP2001310939A5 (https=)
JP2004527639A5 (https=)
JP2004331662A5 (https=)
AR053559A1 (es) Compuestos derivados antibacterianos de 2,4' -dihidroxifenilo 3',5-disustituidos y metodos relacionados
ATE453615T1 (de) Höhere fettsäuretriesterverbindung mit diethylentriaminartiger metallchelatstruktur
DE69624827D1 (de) 5'-substitutierte-ribofuranosyl benzimidazolen als antivirale.
FR2869907B1 (fr) Derives dimeriques de 5,6-diphenyl-1,2,4-triazine et leurs utilisations
EP0860169A3 (en) Compositions for oral administration containing pyridazinone compounds
JP2008024686A5 (https=)
CO5160305A1 (es) Derivados de 2-alcoxi-ciclobuten-3,4-diona su preparacion y su aplicacion en terapeutica
KR930023031A (ko) 아졸 유도체를 함유하는 항아로마타제제
JPH10231284A5 (https=)
WO2007122333A2 (fr) Procede pour l'obtention de disulfures et thiosulfinates et composes obtenus
WO2004066760A3 (en) Composition
JP2006176509A5 (https=)